ATE20517T1 - Theophyllintablette mit kontrollierter wirkstoffabgabe und verfahren zu deren herstellung. - Google Patents

Theophyllintablette mit kontrollierter wirkstoffabgabe und verfahren zu deren herstellung.

Info

Publication number
ATE20517T1
ATE20517T1 AT83402073T AT83402073T ATE20517T1 AT E20517 T1 ATE20517 T1 AT E20517T1 AT 83402073 T AT83402073 T AT 83402073T AT 83402073 T AT83402073 T AT 83402073T AT E20517 T1 ATE20517 T1 AT E20517T1
Authority
AT
Austria
Prior art keywords
weight
ratio
tablet
polymer
theophyllin
Prior art date
Application number
AT83402073T
Other languages
English (en)
Inventor
Joel Bougaret
Daniel Darbeau
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Application granted granted Critical
Publication of ATE20517T1 publication Critical patent/ATE20517T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT83402073T 1982-11-03 1983-10-25 Theophyllintablette mit kontrollierter wirkstoffabgabe und verfahren zu deren herstellung. ATE20517T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8218407A FR2535202B1 (fr) 1982-11-03 1982-11-03 Comprimes de theophylline a liberation controlee et leur procede de fabrication
EP83402073A EP0109320B1 (de) 1982-11-03 1983-10-25 Theophyllintablette mit kontrollierter Wirkstoffabgabe und Verfahren zu deren Herstellung

Publications (1)

Publication Number Publication Date
ATE20517T1 true ATE20517T1 (de) 1986-07-15

Family

ID=9278859

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83402073T ATE20517T1 (de) 1982-11-03 1983-10-25 Theophyllintablette mit kontrollierter wirkstoffabgabe und verfahren zu deren herstellung.

Country Status (8)

Country Link
EP (1) EP0109320B1 (de)
AT (1) ATE20517T1 (de)
CA (1) CA1205385A (de)
DE (1) DE3364276D1 (de)
ES (1) ES526928A0 (de)
FR (1) FR2535202B1 (de)
PT (1) PT77581B (de)
ZA (1) ZA838058B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA836031B (en) * 1983-08-16 1985-02-27 Verex Lab Constant release rate solid dosage theophylline formulation
FR2585948B1 (fr) * 1985-08-06 1988-12-16 Pf Medicament Procede de fabrication de comprimes d'indometacine
FR2588188B1 (fr) * 1985-10-04 1988-01-08 Delalande Sa Comprime de sel(s) hydrosoluble(s) de cinepazide a liberation programmee et son procede de preparation
GB8628728D0 (en) * 1986-12-02 1987-01-07 Euro Celtique Sa Spheroids
FR2618073B1 (fr) * 1987-07-16 1990-09-07 Pf Medicament Comprimes de type a matrice hydrophile a base de salbutamol et leur procede de preparation
GB8813064D0 (en) * 1988-06-02 1988-07-06 Euro Celtique Sa Controlled release dosage forms having defined water content
US5268181A (en) * 1989-04-13 1993-12-07 Upsher-Smith Laboratories, Inc. Method of using niacin to control nocturnal cholesterol synthesis
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US5484607A (en) * 1993-10-13 1996-01-16 Horacek; H. Joseph Extended release clonidine formulation
US5393765A (en) * 1993-12-13 1995-02-28 Hoffmann-La Roche Inc. Pharmaceutical compositions with constant erosion volume for zero order controlled release
US6197340B1 (en) 1998-05-28 2001-03-06 Medical Research Institute Controlled release lipoic acid
WO2003011256A1 (en) * 2001-07-30 2003-02-13 Sun Pharmaceutical Industries Limited Oral controlled release pharmaceutical composition of a prokinetic agent
PT1888080E (pt) * 2005-06-09 2010-07-06 Euro Celtique Sa ComposiãŽes farmac—uticas de um esterëide neuroactivo e as suas utilizaãŽes
EP2155170A2 (de) 2007-06-08 2010-02-24 Addrenex Pharmaceuticals, Inc. Formulierung mit verzögerter freisetzung und verfahren zur behandlung adrenerger unregelmässigkeiten
EP2937096B1 (de) 2014-04-23 2019-08-21 Julius-Maximilians-Universität Würzburg Aus RS1 abgeleitete Peptide, die Glukoseabsorption nach einer glukosereichen Mahlzeit herunterregulieren und die Insulinsensitivität steigern

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2050701C3 (de) * 1969-10-17 1979-12-20 Shinetsu Chemical Co., Tokio Verwendung eines pulverförmigen Celluloseäthers als Hilfsstoff zur Herstellung von leicht zerfallbaren festen Arzneiformen
JPS4917565B1 (de) * 1970-12-29 1974-05-01
AT347039B (de) * 1972-11-03 1978-12-11 Ohrenberger Franz X Dr Verfahren zur herstellung von tabletten und dragees mit einem gehalt an zwei verschiedenen heilmittelwirkstoffen mit verzoegerter wirk- stoffabgabe
JPS55153715A (en) * 1979-05-18 1980-11-29 Nikken Kagaku Kk Prolonged granule of theophylline
US4259314A (en) * 1979-12-10 1981-03-31 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals
JPS56122311A (en) * 1980-02-29 1981-09-25 Eisai Co Ltd Lasting theophylline pharmaceutical composition

Also Published As

Publication number Publication date
ZA838058B (en) 1984-06-27
ES8405618A1 (es) 1984-07-01
PT77581B (fr) 1986-03-18
FR2535202B1 (fr) 1985-08-09
CA1205385A (fr) 1986-06-03
EP0109320A1 (de) 1984-05-23
EP0109320B1 (de) 1986-06-25
DE3364276D1 (en) 1986-07-31
ES526928A0 (es) 1984-07-01
PT77581A (fr) 1983-11-01
FR2535202A1 (fr) 1984-05-04

Similar Documents

Publication Publication Date Title
ATE20517T1 (de) Theophyllintablette mit kontrollierter wirkstoffabgabe und verfahren zu deren herstellung.
AU616449B2 (en) Controlled release combination of carbidopa/levodopa
DE69732113T2 (de) Schnelllösliche tablette enthaltend galanthaminhydrobromid
ES2065461T5 (es) Unidades de administracion de un farmaco de liberacion constante.
US4983400A (en) Controlled release combination of carbidopa/levodopa
NO149490B (no) Fremgangsmaate ved fremstilling av tabletter med regulert frigjoerelse av den aktive bestanddel
SI9111227B (sl) Farmacevtski preprat z aktivno materijo Flupirtin za zdravljenje bolezni, ki se nanašajo na napetost mišic
CA2041774A1 (en) Use of cross-linked amylose as a matrix for the slow release of biologically active compounds
ATE53038T1 (de) Inositoltriphosphat, verfahren zu seiner herstellung und dieses enthaltende zubereitung.
AU1358695A (en) Nasal administration
NO167360C (no) Tverrbundede, poroese polymerer for regulert legemiddelavgivning.
NO176232C (no) Fremgangsmåte for fremstilling av en fast, oral doseringsform med regulert frigivelse av medikament
ATE246505T1 (de) Zubereitung enthaltend cefaclor oder cephalexin mit modifizierter freisetzungsmatrix
SE8405615L (sv) Farmaceutiska tabletter med depaverkan och forfarande for deras framstellning
ITMI922826A1 (it) Composizione farmaceutica a rilascio controllato in sospensione liquida
ATE23266T1 (de) Pharmazeutische produkte in formen mit verzoegerter abgabe und verfahren an deren herstellung.
OA08018A (fr) Matrice inerte à base de polycaprolactone pour administration orale d'un médicament, et procédé de préparation de la forme galénique comprenant cette matrice.
ATE172112T1 (de) Verfahren zur herstellung eines retardpräparates, das diltiazem in einer einzigen tagesdosis enthält
DE2520978C3 (de) Dosierungseinheit einer festen, oral zu verabreichenden Arzneiform von wasserlöslichen Xanthin-Derivaten
TNSN90021A1 (fr) Procede de preparation de tetrahydroimidazo (1,4) benzodiazepin -2- thiones antivirales
EP0374096A1 (de) 2',3'-Dideoxypurinnucleosid/Purinnucleosid-Phosphorylase-Inhibitor Kombinationstherapie und Zusammensetzungen dafür
ATE22282T1 (de) Pentacycloundecan derivate, verfahren zu ihrer herstellung, und diese enthaltende pharmazeutische zusammensetzungen.
CH660303A5 (de) Analgetische praeparate.
KR880004810A (ko) 소화성 궤양 치료제
EP3335700A1 (de) Feste pharmazeutische orale darreichungsform mit verlängerter wirkstofffreisetzung umfassend mirabegron

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time